https://www.selleckchem.com/pr....oducts/durvalumab.ht
18--12.83]; = 0.002). Mean urine output (-112.68 [-27.43-48.9], = 0.17), incidence of AKI (RR = 1.05 [0.80-1.37], = 0.72), and mortality rates (RR = 0.79 [0.42-1.47], = 0.45) were found to be statistically insignificant. Aminophylline administration in children with AKI reduces serum creatinine level without significant adverse effects or effect on the incidence of AKI, urine output, or mortality. Further, large-scale well-planned randomized controlled trials are needed to evaluate its use and its potential long-term effects. Aminoph